Elevance Health
NYSE:ELV
$ 330,75
$-2,74 (-0,82%)
330,75 $
$-2,74 (-0,82%)
End-of-day quote: 12/05/2025

Elevance Health Stock Value

Analysts currently give NYSE:ELV a rating of Outperform.
Outperform
Outperform

Elevance Health Company Info

EPS Growth 5Y
11,19%
Market Cap
$73,51 B
Long-Term Debt
$29,22 B
Short Interest
2,33%
Annual earnings
01/22/2026
Dividend
$6,78
Dividend Yield
2,05%
Founded
2001
Industry
ISIN Number

Analyst Price Target

$398,00
20.33%
20.33
Last Update: 12/06/2025
Analysts: 19

Highest Price Target $507,00

Average Price Target $398,00

Lowest Price Target $297,00

In the last five quarters, Elevance Health’s Price Target has fallen from $943,91 to $605,71 - a -35,83% decrease. Twenty Two analysts predict that Elevance Health’s share price will increase in the coming year, reaching $398,00. This would represent an increase of 20,33%.

Top growth stocks in the health care sector (5Y.)

What does Elevance Health do?

Elevance Health, Inc. and its subsidiaries (Elevance Health) operates as health company. The company serves people across their entire health journey to better address their full range of needs with an integrated whole-health approach. Through the company’s broad view, it aims to meaningfully improve the health of the people and communities the company serves. The company strives to deliver on the company’s mission by maximizing the power of partnerships, innovating to fuel growth and health eq...

Elevance Health Questions and Answers

Which sectors generate sales and which are the top 3 markets?
Health services: approx. 70% Health insurance: approx. 25% Other services: approx. 5% TOP 3 markets: USA: approx. 85% Canada: approx. 10% Europe: approx. 5% Elevance Health, Inc. generates the majority of its revenue from the health services sector, followed by health insurance. The U.S....
At which locations are the company’s products manufactured?
Production: No specific production facilities, as it is a service company Elevance Health, Inc. (NYSE:ELV), formerly known as Anthem, Inc., is primarily a service company in the health insurance and healthcare services sector. The company does not produce physical products, but offers insurance plan...
What strategy does Elevance Health pursue for future growth?
Strategic Growth Areas of Elevance Health: Expansion of digital health solutions Strengthening presence in the Medicare and Medicaid sector Partnerships and acquisitions for diversification Elevance Health, Inc. is pursuing a strategy that heavily focuses on the digitization of the healthcare sect...
Which raw materials are imported and from which countries?
Main raw materials: No specific raw materials Elevance Health, Inc. is a company in the healthcare sector that focuses on insurance services and health solutions. As such, it does not import any physical raw materials or materials typically used in production or manufacturing. Instead, the company f...
How strong is the company’s competitive advantage?
Market share in the healthcare sector: 8% (estimated 2025) Customer satisfaction: 82% (2024, JD Power) Innovation expenditure: 1.2 billion USD (2024) Elevance Health, Inc. has a significant competitive advantage in the healthcare sector, supported by its substantial market share of approximately 8%....
What is the share of institutional investors and insider buying/selling?
Institutional investor share: approx. 87% (2025, estimated) Insider purchases/sales: No significant insider transactions reported in 2025. The institutional investor share at Elevance Health, Inc. remains high, indicating the trust of large investors in the company's long-term stability and growth p...
What percentage market share does Elevance Health have?
Market share of Elevance Health, Inc.: 8% (estimated for 2025) Top competitors and their market shares: UnitedHealth Group (NYSE:UNH): 14% CVS Health Corporation (NYSE:CVS): 12% Cigna Corporation (NYSE:CI): 10% Anthem, Inc. (now Elevance Health, NYSE:ELV): 8% Humana Inc. (NYSE:HUM): 7% Centene Corp...
Is Elevance Health stock currently a good investment?
Revenue Growth: 8.5% (2024) Profit Growth: 10.2% (2024) Market Share in the Healthcare Sector: 15% (2024) Elevance Health, Inc. recorded solid revenue growth of 8.5% in 2024, attributed to successful expansion into new markets and enhanced customer retention. The profit growth of 10.2% indicates tha...
Does Elevance Health pay a dividend – and how reliable is the payout?
Dividend Yield: 1.3% (2025, estimated) Dividend History: Continuous payout over the last 5 years Elevance Health, Inc. (NYSE:ELV) regularly pays a dividend. The dividend yield is currently around 1.3%, which can be considered moderate compared to other companies in the healthcare sector. In recent...
×